Aize Kijlstra Selected Research

HLA-DR53

5/2009	Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
1/2008	Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aize Kijlstra Research Topics

Disease

42	Uveitis 01/2023 - 03/2007
41	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2021 - 05/2007
31	Behcet Syndrome (Behcet's Syndrome) 01/2021 - 08/2008
20	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 05/2006
16	Inflammation (Inflammations) 01/2023 - 05/2006
14	Anterior Uveitis 04/2021 - 01/2013
10	Retinal Detachment (Retinal Detachments) 08/2012 - 11/2004
8	Ankylosing Spondylitis 01/2018 - 01/2013
8	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 03/2002
6	Proliferative Vitreoretinopathy 08/2012 - 11/2004
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2013
5	Cataract (Cataracts) 01/2020 - 07/2012
4	Hypersensitivity (Allergy) 01/2012 - 06/2006
4	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2010 - 03/2002
3	Retinal Vasculitis 03/2021 - 01/2013
3	Necrosis 01/2020 - 01/2014
2	Keratitis 01/2021 - 01/2019
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020 - 01/2013
2	Glaucoma 09/2011 - 03/2002
2	Epiretinal Membrane (Epiretinal Membranes) 10/2010 - 07/2006
2	Retinal Perforations 10/2010 - 07/2006
1	Corneal Injuries 01/2021
1	Encephalomyelitis (Myeloencephalitis) 01/2021

Drug/Important Bio-Agent (IBA)

13	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2007
9	Messenger RNA (mRNA)IBA 09/2022 - 03/2007
8	Retinaldehyde (Retinal)IBA 01/2021 - 03/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2009
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
6	AntigensIBA 01/2018 - 05/2006
6	LuteinIBA 01/2017 - 07/2012
6	InterleukinsIBA 01/2015 - 05/2006
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2022 - 05/2009
5	CytokinesIBA 01/2021 - 08/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2012
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2016
4	Peptides (Polypeptides)IBA 01/2023 - 05/2006
4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 05/2007
4	LigandsIBA 01/2020 - 01/2011
4	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2012
4	Complement System Proteins (Complement)IBA 08/2015 - 01/2015
4	Interleukin-10 (Interleukin 10)IBA 01/2015 - 05/2006
3	EnzymesIBA 01/2023 - 10/2008
3	ImmunosorbentsIBA 01/2023 - 10/2008
3	InterferonsIBA 01/2020 - 05/2006
3	Interleukin-4 (Interleukin 4)IBA 09/2017 - 05/2006
3	ChemokinesIBA 01/2017 - 07/2009
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016 - 01/2008
3	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015 - 07/2009
2	SaltsIBA 01/2023 - 01/2015
2	antineoplaston A10 (A 10)IBA 10/2022 - 01/2013
2	Prednisone (Sone)FDA LinkGeneric 09/2022 - 03/2021
2	Fluorescein (Funduscein)FDA LinkGeneric 03/2021 - 01/2014
2	Amino Acids FDA Link 01/2021 - 07/2006
2	BerberineIBA 04/2020 - 04/2013
2	Monocyte Chemoattractant ProteinsIBA 01/2020 - 01/2010
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2020 - 09/2014
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 01/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2017 - 11/2004
2	Carrier Proteins (Binding Protein)IBA 09/2017 - 04/2016
2	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 08/2017 - 01/2017
2	LipidsIBA 01/2017 - 09/2014
2	C-Type Lectins (C-Type Lectin)IBA 01/2017 - 03/2015
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 09/2014
2	Interleukin-1 (Interleukin 1)IBA 10/2016 - 07/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 08/2010
2	Complement Factor D (Factor D)IBA 04/2015 - 01/2015
2	P-2 (P 2)IBA 03/2015 - 02/2014
2	Complement C4 (Complement Component 4)IBA 01/2015 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014 - 07/2009
2	Interleukin-27 (Interleukin 27)IBA 05/2014 - 07/2012
2	TNF Receptor-Associated Factor 5IBA 01/2014 - 01/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013 - 01/2012
2	EndotoxinsIBA 07/2012 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 01/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2011 - 01/2007
2	HLA-DR53IBA 05/2009 - 01/2008
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2009 - 01/2008
2	Fc Receptors (Fc Receptor)IBA 05/2009 - 01/2008
2	Interleukin-23 Subunit p19IBA 07/2008 - 05/2007
1	InflammasomesIBA 01/2023
1	ElementsIBA 01/2023
1	SterolsIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Air Pollutants (Pollutants, Air)IBA 10/2022
1	LuciferasesIBA 01/2022
1	HLA-A*26 antigenIBA 01/2022
1	ChromatinIBA 01/2022
1	Linoleic Acid (Linoleate)IBA 04/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Toll-Like Receptor 10IBA 10/2020
1	palmitoleic acidIBA 07/2020
1	IGF-I-IGFBP-3 complex FDA Link 01/2020

Therapy/Procedure

3	Transplantation 01/2021 - 01/2018
3	Therapeutics 01/2019 - 11/2008
3	Scleral Buckling 08/2012 - 01/2007
2	Corneal Transplantation (Keratoplasty) 01/2021 - 01/2019
2	Phacoemulsification 12/2018 - 08/2012
1	Penetrating Keratoplasty 01/2021
1	Organ Transplantation 01/2020